Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Real World-effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets in Subjects With Allergic Rhinitis With or Without Asthma: Results From a Multinational, Retrospective Register Study

NCT05476484 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT05476484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Real World-effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets in Subjects With Allergic Rhinitis With or Without Asthma: Results From a Multinational, Retrospective Register Study
Lead sponsor
ALK-Abelló A/S
Phase
Observational
Overall status
Completed
Start date
April 1, 2022
Completion date
June 30, 2024
Enrollment
46,196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, allergy, asthma